AC
TMO icon

ASB Consultores’s Thermo Fisher Scientific TMO Stock Holding History

ASB Consultores’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-644
Closed -$261K – 129
2025
Q2 		$261K Buy
644
+70
+12% +$29.3K 0.17% 105
2025
Q1 		$286K Sell
574
-444
-44% -$240K 0.19% 82
2024
Q4 		$530K Sell
1,018
-38
-4% -$20.9K 0.22% 70
2024
Q3 		$653K Buy
1,056
+271
+35% +$160K 0.26% 61
2024
Q2 		$434K Sell
785
-152
-16% -$87.1K 0.16% 88
2024
Q1 		$545K Buy
+937
New +$526K 0.14% 108
2023
Q4 		– Sell
-445
Closed -$225K – 159
2023
Q3 		$225K Sell
445
-247
-36% -$132K 0.09% 119
2023
Q2 		$361K Sell
692
-88
-11% -$47.5K 0.18% 116
2023
Q1 		$450K Buy
780
+165
+27% +$93K 0.18% 83
2022
Q4 		$339K Sell
615
-296
-32% -$157K 0.14% 111
2022
Q3 		$462K Buy
911
+531
+140% +$297K 0.22% 58
2022
Q2 		$206K Sell
380
-898
-70% -$494K 0.09% 167
2022
Q1 		$755K Buy
1,278
+388
+44% +$223K 0.32% 44
2021
Q4 		$594K Buy
+890
New +$556K 0.29% 66

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

ASB Consultores's TMO Position: Q3 2025 in Review

ASB Consultores sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 644 shares — an estimated $261K sold.

ASB Consultores first reported a position in TMO in Q4 2021 and held it in 14 quarters. The position peaked at $755K in Q1 2022. 2,515 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • ASB Consultores reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • ASB Consultores sold 644 Thermo Fisher Scientific shares in Q3 2025, an estimated $261K.
  • ASB Consultores first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 14 quarters.
  • ASB Consultores's Thermo Fisher Scientific position peaked at $755K in Q1 2022.
  • 2,515 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on ASB Consultores's 13F filing for Q3 2025, filed 4 Nov 2025.